Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

narcolepsy

NLS Pharmaceutics (NLSP.Q) announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for Quilience® extended release, the Company’s lead drug…